MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Exploring the Impact of Parameter Selection on Digital Sleep Outcomes in Parkinson’s Disease: Results from the IDEA-FAST Study

    M. Sedghi, S. Del Din, W-F. Ng, W. Maetzler, NV. Manyakov, S. Avey, R. Göder, C. Pinaud, M. Chatterjee, RZ. Ur Rehman, JP. Taylor, L. Alcock, RA. Lawson (Newcastle upon Tyne, United Kingdom)

    Objective: To assess the impact of ad-hoc thresholds used for sleep outcome quantification from wearable accelerometers in Parkinson’s disease (PD). Background: Sleep problems affect up…
  • 2026 International Congress

    Targeting the Immunoproteasome PSMB8: A dual strategy to enhance α-synuclein clearance and mitigate CD8+ T-Cell neurotoxicity in Parkinson’s Disease

    HD. Nguyen, HBT. Tran, TT. Nguyen, IH. Kwak, YJ. Kim, H. Ma, HJ. Kim, YE. Kim (Anyang, Republic of Korea)

    Objective: To determine if the immunoproteasome (IP) subunit PSMB8 serves as a pathological link between α-synuclein aggregation and cytotoxic immune responses in Parkinson’s disease (PD).…
  • 2026 International Congress

    Young-Onset Parkinson’s Disease with Coexisting GBA1 Mutation and ATXN3 Repeat Expansion: A Double Hit?

    D. Yoo, K. Park, T. Ahn (Seoul, Republic of Korea)

    Objective: To report a rare case of young-onset Parkinson’s disease (PD) with a positive family history in which the patient was found to harbor double…
  • 2026 International Congress

    DCN-PPN Pathway Activation Improves Motor Dysfunction via Synaptic Plasticity in Parkinson’s Disease

    L. Liao, Z. Zhang (Guangzhou, Guangdong Province, China)

    Objective: To define the anatomical and functional connectivity of the DCN-PPN pathway, determine its alterations in PD, and investigate whether impaired synaptic plasticity in this…
  • 2026 International Congress

    Deep Brain Stimulation Outcomes in Parkinson’s Disease Patients With GBA1 Variants: A Systematic Review and Meta-analysis

    A. Hegazi, R. Mohamed, H. Hussein (Mansoura, Egypt)

    Objective: To compare motor, cognitive, and medication outcomes following deep brain stimulation (DBS) in Parkinson’s disease patients with GBA1 variants versus non-carriers Background: Variants in…
  • 2026 International Congress

    Early-Onset Parkinson Disease in 22q11.2 Deletion Syndrome:Diagnostic Challenges in a Patient With Schizophrenia.A Case Report

    L. Salinas-Yañez, J. Altamirano, D. Avecilla-Bonilla, K. Salinas-Barboza (CDMX, Mexico)

    Objective: To highlight 22q11.2 deletion syndrome (22q11.2DS) as an underrecognized genetic cause of early-onset Parkinson disease (EOPD) and to describe the diagnostic challenges in patients…
  • 2026 International Congress

    Plasma Proteomics in PSP

    S. Neo, S. Chia, J. Tan, T. Leong, Z. Xu, KY. Tay, WL. Au, LCS. Tan, A. Ng (Singapore, Singapore)

    Objective: We implemented an unbiased proximity extension proteomics assay to identify novel plasma PSP biomarkers. Background: Blood-based biomarkers can help to support non-invasive early diagnosis…
  • 2026 International Congress

    Various Levodopa Formulation effects on Local Field Potentials in Parkinson’s Disease

    A. Madamangalam, J. Cagle, C. de Hemptinne, J. Wong (Gainesville, USA)

    Objective: To describe the electrophysiological changes that occur in the brain with the use of foscarbidopa-foslevodopa and compare it to other common formulations of levodopa…
  • 2026 International Congress

    Modulatory effects of bacterial-derived serine protease on pathological α-synuclein fibrillation in vitro

    HJ. Yang, JI. Choi (Incheon, Republic of Korea)

    Objective: To investigate the modulatory effects of bacterial-derived proteins on the pathological aggregation of α-synuclein (α-syn) Background: Aggregation of α-syn into toxic oligomers and protofibrils…
  • 2026 International Congress

    Motor Network Neurophysiological (TMS-EEG) Markers as Predictors of Long-Term Outcomes Following Ventriculoperitoneal Shunt in Normal Pressure Hydrocephalus

    T. Davidy, A. Suminski, Y. Zauberman, T. Fay-Karmon, S. Anis, A. Saar, N. Zifman, H. Fogel, O. Lesman-Segev, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: Assess the ability of Delphi-MD (TMS-evoked potential (TEP)-based test) to predict long-term (over one year) response to VPS as an ancillary tool to improve decision-making. Background:…
  • « Previous Page
  • 1
  • …
  • 151
  • 152
  • 153
  • 154
  • 155
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley